Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Stroke. 2018 Feb 8;49(3):536–542. doi: 10.1161/STROKEAHA.117.018418

Table 1.

Sex Differences in Risk Factor Prevalence, Associations, and Treatment Disparities, Women Compared with Men

Risk Factor Prevalence Association with IS Treatment Disparity
Hypertension Lower in women (vs. men) in younger age groups, higher in older age groups Similar in women (vs. men) in younger age groups, higher in older age groups In younger age groups, women more likely to have BP controlled; in older age groups, women less likely to have BP controlled.
Dyslipidemia Data conflict; either similar between sexes or lower in women Lower in women Women less likely to be on statins and have LDL controlled.
Atrial Fibrillation Higher in women Higher in women Women less likely to be prescribed oral anticoagulants, less likely to have cardiac ablation, and receive lower doses of NOACs.
Migraine Higher in women Higher in women. Unknown if migraine treatment reduces stroke risk.
Diabetes Similar women vs. men Higher in women Data conflict regarding sex differences in meeting HbA1c goal
Cognitive Impairment Higher in women Unknown whether there is a sex difference Women less likely to be treated with anti-dementia drugs

IS: Ischemic stroke. BP: blood pressure. NOAC: novel oral anticoagulant. HbA1c: glycated hemoglobin